Reverso Therapeutics

Pharmaceutical startup with the mission of commercialising the first anticoagulant with an integrated reversal system. The reversal mechanism is envisioned to be applied for other drug indications where fast reversal is required. The current objective of the co-founders is to gather funds and hire workforce to continue developing the promising proof of concept anticoagulant developed at the University of Geneva. The objective of the company is to at least complete phase II clinical trials and associate with a larger pharmaceutical company that can take care of distribution and commercialisation.